0001209191-20-044542.txt : 20200803
0001209191-20-044542.hdr.sgml : 20200803
20200803175444
ACCESSION NUMBER: 0001209191-20-044542
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200730
FILED AS OF DATE: 20200803
DATE AS OF CHANGE: 20200803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORTON DAVID H JR
CENTRAL INDEX KEY: 0001476070
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38698
FILM NUMBER: 201070422
MAIL ADDRESS:
STREET 1: SEAGATE TECHNOLOGY
STREET 2: 920 DISC DRIVE
CITY: SCOTTS VALLEY
STATE: CA
ZIP: 95066
FORMER NAME:
FORMER CONFORMED NAME: MORTON DAVID H
DATE OF NAME CHANGE: 20091103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anaplan, Inc.
CENTRAL INDEX KEY: 0001540755
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 270897861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 50 HAWTHORNE STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-742-8199
MAIL ADDRESS:
STREET 1: 50 HAWTHORNE STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-30
0
0001540755
Anaplan, Inc.
PLAN
0001476070
MORTON DAVID H JR
50 HAWTHORNE STREET
SAN FRANCISCO
CA
94105
0
1
0
0
Chief Financial Officer
Common Stock
2020-07-30
4
S
0
25099
45.0467
D
30620
D
Common Stock
2020-07-30
4
M
0
4901
11.86
A
35521
D
Common Stock
2020-07-30
4
S
0
4901
45.0692
D
30620
D
Stock Option (right to buy)
11.86
2020-07-30
4
M
0
4901
0.00
D
2028-09-13
Common Stock
4901
144064
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45 to $45.21, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
The Form 4 filed by the Reporting Person on June 12, 2020, inadvertently overstated the number of securities beneficially owned by the Reporting Person by 282 shares of common stock. The total reported in Column 5 corrects for that overstatement.
This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45 to $45.18, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
25% of the stock option vested on September 10, 2019, with the remainder exercisable in 36 equal monthly installments thereafter provided that the Reporting Person remains in continuous service on each vesting date; the option may also be exercised early subject to Issuer's right of repurchase.
/s/ Gary Spiegel, Attorney-in-Fact
2020-08-03